Solace Therapeutics: Solace Therapeutics Announces that Tri Valley Urology Enrolls First Patient in US Pivotal Clinical Trial, using New Office-Based Treatment for Female Stress Urinary Incontinence(SUI).

(marketscreener.com) Tri Valley Urology, has enrolled their first patient in the VESAIR Clinical Trial. The VESAIR Clinical Trial is being conducted in several distinguished clinics throughout the US to test the safety and efficacy of the Vesair Bladder Control Balloon procedure. This press release features multimedia. View the full release here:...https://www.marketscreener.com/news/latest/Solace-Therapeutics-Announces-that-Tri-Valley-Urology-Enrolls-First-Patient-in-US-Pivotal-Clinical-T--33027110/?utm_medium=RSS&utm_content=20210421